vivaldibiosciences.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* | ||
Meta Tags
| Title | Vivaldi |
| Description | DeltaFLU Developing nasal-spray, self-adjuvanting vaccines for viral respiratory diseases based on our Delta NS1 technology platform: DeltaFLU: Universal Influenza Vaccine in Phase 2 clinical development for broad protection against all strains of |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.185.159.144 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
vivaldibiosciences.com Valuation
|
US$5,445,974
Last updated: 2022-07-10 04:25:00
vivaldibiosciences.com has Semrush global rank of 1,943,510. vivaldibiosciences.com has an estimated worth of US$ 5,445,974, based on its estimated Ads revenue. vivaldibiosciences.com receives approximately 628,382 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.144. According to SiteAdvisor, vivaldibiosciences.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,445,974 |
| Daily Ads Revenue | US$5,028 |
| Monthly Ads Revenue | US$150,812 |
| Yearly Ads Revenue | US$1,809,739 |
| Daily Unique Visitors | 41,893 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| vivaldibiosciences.com. | A | 3600 | IP: 198.185.159.144 |
| vivaldibiosciences.com. | A | 3600 | IP: 198.185.159.145 |
| vivaldibiosciences.com. | A | 3600 | IP: 198.49.23.144 |
| vivaldibiosciences.com. | A | 3600 | IP: 198.49.23.145 |
| vivaldibiosciences.com. | NS | 3600 | NS Record: ns16.domaincontrol.com. |
| vivaldibiosciences.com. | NS | 3600 | NS Record: ns15.domaincontrol.com. |
| vivaldibiosciences.com. | MX | 3600 | MX Record: 20 east.smtp.exch084.serverdata.net. |
| vivaldibiosciences.com. | MX | 3600 | MX Record: 10 west.smtp.exch084.serverdata.net. |
HtmlToTextCheckTime:2022-07-10 04:25:00
| Home DeltaFlu Delta-19 About Vivaldi News Publications Contact us Home DeltaFlu Delta-19 About Vivaldi News Publications Contact us Scroll Delta NS1 Vaccine Platform Delta NS1 is a versatile and robust technology platform for broadly protective, self-adjuvanting vaccines administered by nasal spray. Delta NS1 is a replication-deficient vaccine vector based on a genetically modified, safely attenuated influenza virus strain. Vivaldi Biosciences is developing Delta NS1 vaccines for protection against epidemic and pandemic viral respiratory diseases. Delta NS1-based vaccines have the unique ability to rapidly induce interferon, generating protection against circulating viruses entering the nasal passages, and activating systemic antibody and cell-based protective immunity. Interferon is signaling protein in the body that acts as an early-warning system and triggers a broad-based immune response. Naturally occurring influenza viruses produce NS1 to block the body’s interferon |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 374422 Date: Tue, 26 Oct 2021 14:46:46 GMT Location: https://vivaldibiosciences.com/ Server: Squarespace Set-Cookie: crumb=BZhLY9uFMb26NTUxNTMxNGNjYTVhNmYyMWZiZDExZDM5MTFiMTI4;Path=/ X-Contextid: rvU1dtvO/JuPRxypz HTTP/2 200 accept-ranges: bytes age: 449438 content-type: text/html;charset=utf-8 date: Mon, 25 Oct 2021 17:56:31 GMT etag: W/"f758a6d68c67eccf0960c3f805ec6b10" expires: Thu, 01 Jan 1970 00:00:00 GMT last-modified: Mon, 25 Oct 2021 14:16:20 GMT server: Squarespace set-cookie: crumb=BQtejUKkFF0cOGJhMmZmNzJkMzE2ZjUwNzU5ZDUzNmExYjYzMWIy;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: HKRwjj1s/mInUDDBU content-length: 16816 |
vivaldibiosciences.com Whois Information
Domain Name: VIVALDIBIOSCIENCES.COM Registry Domain ID: 475475901_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-01-11T21:28:13Z Creation Date: 2006-06-07T00:24:36Z Registry Expiry Date: 2023-06-07T00:24:36Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS15.DOMAINCONTROL.COM Name Server: NS16.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T09:08:11Z <<< |